CNR Institutional Research Information System

DE FRANCISCIS, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.454
NA - Nord America 673
SA - Sud America 352
EU - Europa 343
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.865
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 650
US - Stati Uniti d'America 633
CN - Cina 300
BR - Brasile 292
VN - Vietnam 167
HK - Hong Kong 152
IT - Italia 97
FR - Francia 87
KR - Corea 57
NL - Olanda 51
JP - Giappone 30
AR - Argentina 24
DE - Germania 23
IN - India 22
MX - Messico 18
GB - Regno Unito 17
CA - Canada 16
BD - Bangladesh 13
FI - Finlandia 13
ZA - Sudafrica 13
EC - Ecuador 11
IL - Israele 10
CO - Colombia 7
IQ - Iraq 7
MA - Marocco 7
TR - Turchia 7
AT - Austria 6
PY - Paraguay 6
UZ - Uzbekistan 6
VE - Venezuela 6
EG - Egitto 5
HU - Ungheria 5
ID - Indonesia 5
RU - Federazione Russa 5
AL - Albania 4
ES - Italia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
GR - Grecia 3
IE - Irlanda 3
PH - Filippine 3
PL - Polonia 3
SA - Arabia Saudita 3
UA - Ucraina 3
UY - Uruguay 3
DZ - Algeria 2
KE - Kenya 2
LT - Lituania 2
MY - Malesia 2
NP - Nepal 2
RO - Romania 2
RS - Serbia 2
SE - Svezia 2
SI - Slovenia 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LY - Libia 1
ME - Montenegro 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZM - Zambia 1
Totale 2.865
Salva come PNG Salva come JPEG
Città #
Singapore 406
Santa Clara 227
Hong Kong 151
Hefei 107
San Jose 75
Lauterbourg 73
Beijing 70
Ho Chi Minh City 63
Seoul 56
Los Angeles 43
Ashburn 37
Hanoi 36
São Paulo 34
New York 22
Tokyo 20
Milan 19
Marigliano 13
Da Nang 11
Frankfurt am Main 11
Naples 11
Curitiba 10
Dallas 10
Buffalo 9
Rio de Janeiro 9
Helsinki 8
Brasília 7
Minamishinagawa 7
Bengaluru 6
Johannesburg 6
London 6
Montreal 6
Orem 6
Tashkent 6
Ascoli Piceno 5
Atlanta 5
Dhaka 5
Guayaquil 5
Houston 5
Hải Dương 5
Quito 5
Amsterdam 4
Baghdad 4
Belo Horizonte 4
Budapest 4
Casandrino 4
Düsseldorf 4
Giugliano in Campania 4
Guarulhos 4
Lappeenranta 4
Phoenix 4
Asunción 3
Biên Hòa 3
Bogotá 3
Cairo 3
Campinas 3
Campos dos Goytacazes 3
Cape Town 3
Caruaru 3
Casablanca 3
Chennai 3
Chicago 3
Dublin 3
Genoa 3
Louisville 3
Manaus 3
Phủ Lý 3
Porto Alegre 3
Rosario 3
Salvador 3
Sorocaba 3
São Gonçalo 3
Vũng Tàu 3
Alegrete 2
Alfenas 2
Almirante Tamandaré 2
Aracaju 2
Baku 2
Barretos 2
Berlin 2
Boydton 2
Byron 2
Caracas 2
Catanduva 2
Ciudad del Este 2
Cà Mau 2
Dakar 2
Diadema 2
Dubai 2
Falkenstein 2
Feira de Santana 2
Glendora 2
Goiânia 2
Guangzhou 2
Haiphong 2
Islamabad 2
Jakarta 2
Jundiaí 2
Luton 2
Maldonado 2
Marília 2
Totale 1.778
Salva come PNG Salva come JPEG
Nome #
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation 78
Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor 76
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 76
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 70
Selection of a nuclease‐resistant rna aptamer targeting cd19 69
Aptamer-based RNA-bio-drugs for the combined therapy of GBM 60
Diagnostic and Therapeutic Aptamers A Promising Pathway to Improved Cardiovascular Disease Management 60
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR beta Aptamer 59
A Theranostic "SMART" Aptamer for Targeted Therapy of Prostate Cancer. 55
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 52
A regulatory mechanism involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the control of cell proliferation. 51
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells 50
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 50
Nucleic acid aptamers targeting epigenetic regulators: An innovative therapeutic option 48
STAT3 targeting by an aptamer-based conjugate for glioblastoma multiforme therapy 48
Affinity immobilization of aptamers on graphene oxide for biosensor applications 47
GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. 46
Signaling through Ras Is Essential for ret Oncogene-induced Cell Differentiation in PC12 Cells 44
Identification of an interfering ligand aptamer for EphB2/3 receptors 44
Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3 44
Engineering Aptamers for Biomedical Applications: Part II 43
Targeting breast cancer exosomes with nucleic aptamers: Innovative tools for early diagnosis and therapy 43
Aptamer chimeras for therapeutic delivery: The challenging perspectives 42
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 41
Nucleic acids delivering nucleic acids 41
RET/PTC activation in human thyroid carcinomas 40
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma 39
The isolectin IB4 binds RET receptor tyrosine kinase in microglia. 37
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death 37
Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates 36
Abrogation of Nerve Growth Factor-induced Terminal Differentiation by ret Oncogene Involves Perturbation of Nuclear Translocation of ERK 34
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis 33
Aptamers in Bordeaux, 24-25 June 2016 33
Targeting Insulin Receptor with a Novel Internalizing Aptamer. 33
A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells 32
Use of yeast artificial chromosomes to study the genomic organization of human dbl proto-oncogene. 32
Distribution and bioactivity of the Ret-specific D4 aptamer in three-dimensional collagen gel cultures. 32
Aptamer-miRNA conjugates for cancer cell-targeted delivery 32
A trans-disciplinary approach to cancer research 32
Expression of GFRalpha1 receptor splicing variants with different biochemical properties is modulated during kidney development . 32
Nucleic acid aptamers for in vivo molecular imaging 31
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 31
Noncoding RNAs in Cancer Medicine. 30
cleic acids in human glioma treatment: innovative approaches and recent results 30
The recent blooming of therapeutic aptamers 30
Cell-specific aptamers for targeted therapies. 30
Aptamers are an innovative and promising tool for phytoplankton taxonomy and biodiversity research 28
Challenging cancer targets for aptamer delivery. 28
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR? Aptamer. 28
Arresting the colonial destiny of metastatic seeds with DNA aptamers. 27
Thyrotropin stimulates transcription from the ferritin heavy chain promoter 27
A Trojan horse for human immunodeficiency virus 27
Coupling aptamers to short interfering RNAs as therapeutics 27
Shp2 in PC12 cells: NGF versus EGF 27
Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells 27
Differential SELEX in human glioma cell lines. 27
New insight into clinical development of nucleic acid aptamers. 27
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models 27
Smooth muscle cell-targeted RNA aptamer inhibits neointimal formation 27
Aptamer-mediated targeted delivery of therapeutics: An update 26
SERS-active metal-dielectric nanostructures integrated in microfluidic devices for label-free quantitative detection of miRNA 26
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL 25
A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation. 25
Direct interactions among the tyrosine kinase receptor Ret, the GDNF and the GFR±1 molecules. 25
Developing aptamers by cell-based SELEX 25
ANALYSIS AND SEQUENCING OF THE GENOMIC DNA REGION SPANNING THE HUMAN DBL PROTOONCOGENE 25
Recent advance in biosensors for microRNAs detection in cancer 25
5'-End ret splicing: absence of variants in normal tissues and intron retention in pheochromocytomas. 25
Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKs): Evidence for a divergence of the ERKs and JNKs pathways induced by Ret 24
TSH regulation of ferritin H chain messenger RNA levels in the rat thyroids 24
Targeting cancer cells with nucleic acid aptamers 24
An Autocrine Loop Involving Ret and Glial Cell-Derived Neurotrophic Factor Mediates Retinoic Acid-Induced Neuroblastoma Cell Differentiation 23
Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase 23
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells 22
Aptamer-Based Technologies as New Tools for Proteomics in Diagnosis and Therapy Frontiers in Drug Design & Discovery 22
Human dbl proto-oncogene in 85 kb of Xq26, and determination of the transcription initiation site. 21
In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing 21
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells 20
Changes in cellular gene expression in rat thyroid epithelial cells transformed by the Kirsten Murine Sarcoma Virus 20
Ligand stimulation of a RET chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B 19
Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors 19
Human dbl proto-oncogene in 85 kb of Xq26, and determination of the transcription initiation site 19
The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination 17
Nucleic Acid-Based Aptamers As Promising Therapeutics In Neoplastic Diseases 17
Totale 2.949
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.803
article - articoli 9.058
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 491
Totale 19.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202432 0 0 0 0 0 0 0 0 1 0 20 11
2024/20251.148 8 4 95 40 213 48 51 51 39 73 266 260
2025/20261.769 75 170 213 317 291 86 257 102 79 119 60 0
Totale 2.949